Activist 13D/13G Filings - Protagonist Therapeutics, Inc. (PTGX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-04-13
4:30 pm
Purchase
13GProtagonist Therapeutics, Inc.
PTGX
ADAGE CAPITAL PARTNERS GP L.L.C.2,955,000
5.44%
1,804,955increase
(+156.95%)
View
2023-03-20
5:04 pm
Purchase
13GProtagonist Therapeutics, Inc.
PTGX
BIOTECHNOLOGY VALUE FUND L P5,025,900
9.6%
3,775,900increase
(+302.07%)
View
2023-02-14
4:11 pm
Sale
13GProtagonist Therapeutics, Inc.
PTGX
Point72 Asset Management L.P.368,006
0.7%
-2,052,303decrease
(-84.80%)
View
2023-02-14
10:04 am
Purchase
13GProtagonist Therapeutics, Inc.
PTGX
RTW INVESTMENTS LP3,591,986
7.3%
992,164increase
(+38.16%)
View
2023-02-13
6:19 pm
Sale
13GProtagonist Therapeutics, Inc.
PTGX
BIOTECHNOLOGY VALUE FUND L P1,250,000
2.5%
-3,641,945decrease
(-74.45%)
View
2023-02-09
4:54 pm
Purchase
13GProtagonist Therapeutics, Inc.
PTGX
Farallon Capital Partners L.P.5,055,102
9.99%
5,055,102increase
(New Position)
View
2023-02-09
11:30 am
Purchase
13GProtagonist Therapeutics, Inc.
PTGX
VANGUARD GROUP INC3,097,714
6.3%
3,097,714increase
(New Position)
View
2023-01-31
1:58 pm
Purchase
13GProtagonist Therapeutics, Inc.
PTGX
BlackRock Inc.
BLK
3,652,157
7.4%
370,521increase
(+11.29%)
View
2023-01-11
1:00 pm
Unchanged
13GProtagonist Therapeutics, Inc.
PTGX
JOHNSON & JOHNSON
JNJ
2,449,183
4.98%
0
(Unchanged)
View
2023-01-10
08:18 am
Sale
13GProtagonist Therapeutics, Inc.
PTGX
STATE STREET CORP
STT
3,792,926
7.71%
-2,983,343decrease
(-44.03%)
View
2023-01-03
4:22 pm
Purchase
13GProtagonist Therapeutics, Inc.
PTGX
CITADEL ADVISORS LLC2,682,814
5.5%
2,682,814increase
(New Position)
View
2022-12-12
08:41 am
Sale
13GProtagonist Therapeutics, Inc.
PTGX
FMR LLC385,863
0.784%
-3,168,232decrease
(-89.14%)
View
2022-07-11
11:51 am
Purchase
13GProtagonist Therapeutics, Inc.
PTGX
STATE STREET CORP
STT
6,776,269
13.93%
4,204,699increase
(+163.51%)
View
2022-06-10
11:04 am
Sale
13GProtagonist Therapeutics, Inc.
PTGX
FMR LLC3,554,095
7.304%
-3,293,182decrease
(-48.09%)
View
2022-02-14
4:34 pm
Sale
13GProtagonist Therapeutics, Inc.
PTGX
Point72 Asset Management L.P.2,420,309
5.1%
-1,908,721decrease
(-44.09%)
View
2022-02-14
1:57 pm
Sale
13GProtagonist Therapeutics, Inc.
PTGX
Consonance Capital Management LP0
0%
-2,729,709decrease
(Position Closed)
View
2022-02-14
08:07 am
Sale
13GProtagonist Therapeutics, Inc.
PTGX
RTW INVESTMENTS LP2,599,822
5.4%
-1,050,247decrease
(-28.77%)
View
2022-02-11
9:03 pm
Purchase
13GProtagonist Therapeutics, Inc.
PTGX
BIOTECHNOLOGY VALUE FUND L P4,891,945
9.99%
616,980increase
(+14.43%)
View
2022-02-11
4:18 pm
Sale
13GProtagonist Therapeutics, Inc.
PTGX
FARALLON CAPITAL MANAGEMENT LLC3,417,134
6.9%
-507,866decrease
(-12.94%)
View
2022-02-10
3:41 pm
Purchase
13GProtagonist Therapeutics, Inc.
PTGX
STATE STREET CORP
STT
2,571,570
5.39%
2,571,570increase
(New Position)
View
Goto 0, 1, 2, Next